top of page
Stargardt Macular Degeneration
Behaviour
- Blurry or distorted vision
Color vision difficulties
Light sensitivity
Preserved peripheral vision
Visual fatigue
Biomarkers
- ABCA4 gene mutations
Optical Coherence Tomography (OCT)
Fundus Autofluorescence (FAF)
Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO)
Pathology
- Genetic basis
Lipofuscin accumulation
RPE dysfunction
Juvenile macular degeneration
Photoreceptor damage
Retinitis Pigmentosa (RP)
Behaviour
- Progressive peripheral vision loss
Difficulty with mobility
Night blindness
Light sensitivity (photophobia)
Anxiety, depression, and feelings of isolation
Biomarkers
- Fundus Autofluorescence (FAF)
Optical Coherence Tomography (OCT)
Electroretinogram (ERG)
Visual field testing
Pathology
- Photoreceptor cell death
Retinal pigment epithelial atrophy
Retinal pigment deposits
Rod-cone dystrophy
Diabetic Retinopathy
Behaviour
- Blurred vision
Floaters
Distorted vision
Vision loss
Color vision changes
Biomarkers
- HbA1c
Interleukin-6 (IL-6)
Retinol-binding protein 4 (RBP4)
Afamin (AFM)
Apolipoproteins
Pathology
- Capillary microaneurysms
Retinal hemorrhages
Oxidative stress
Retinal hypoxia
Breakdown of the blood-retina barrier
Uveitis
Behaviour
- Eye pain
Red eyes
Blurred vision
Sensitivity to light
Floaters
Biomarkers
- Optical coherence tomography (OCT)
Cytokines: TNF-α, IL-17, IL-23, and IL-8
CRALBP, MDH
Thrombospondin (TSP-2)
Pathology
- Cell injury
Cyclitic membrane
Immune response
Granulomatous and nongranulomatous
Adhesions
Geographic Atrophy (GA)
Behaviour
- Progressive vision loss
Early symptoms may be subtle
Blurred or distorted central vision
Impact on daily activities: reading, driving
Reduced night vision
Biomarkers
- CFH gene
LOC387715/ARMS2/HTRA1
C2, C3
Inflammatory cytokines: CRP
Pathology
- Progression: RPE
Visual impact
Photoreceptor cells
Underlying mechanisms: genetic predisposition, chronic inflammation, oxidative stress
Diabetic macular edema (DME)
Behaviour
- Progressive vision loss
Blurred vision
Color perception changes
Difficulty with glare
No pain
Biomarkers
- Intraretinal fluid
SRF
Subretinal fluid (SRF)
Disorganization of the retinal inner layers (DRIL)
Pathology
- Blood-retinal barrier breakdown
Hyperglycemia-induced damage
Vascular endothelial growth factor (VEGF)
Pericyte loss
Oxidative stress
Glaucoma
(Open-Angle Glaucoma)
Behaviour
- Stress
Eye pain or pressure
Headaches
Blurred vision, double vision
Red eye
Biomarkers
- Aqueous humor proteins: OPN, MMP-9, TNF-alpha, TGF-beta, IL-10
Crystallins, heat shock protein 60, HSP 90, myotrophin
VDAC2, PGAM1, and CALD1
Brain-derived neurotrophic factor (BDNF)
Ankyrin-2
Pathology
- Optic nerve damage
Trabecular meshwork abnormalities
Optic nerve cupping
Intraocular pressure (IOP)
Retinal ganglion cell death
Macular Degeneration (AMD - Age-related Macular Degeneration)
Behaviour
- Difficulty reading
Frustration and anxiety
Social isolation
Distorted vision
Blind spots in central vision
Biomarkers
- CFH
PLEKHA1/ARMS2/HtrA1 genes
SERPING1
COL8A1
Pathology
- Retinal pigment epithelium (RPE)
Oxidative stress
Mitochondrial DNA damage
Complement attack
Hypertensive Retinopathy (HR)
Behaviour
- Blurred or double vision
Reduced visual clarity
Headaches
Eye strain
Sudden vision loss
Biomarkers
- Retinal vascular parameters
Ischemia modified albumin (IMA)
Serum uric acid
Microalbuminuria
Direct retinal observation
Pathology
- Arteriolar changes
Arteriovenous (AV) nicking
Macular star
Stroke
Heart attack
Dry Eye Syndrome
Behaviour
- Frequent blinking
Eye rubbing
Squinting
Eyelid discomfort
Blurred vision, redness
Biomarkers
- Lactoferrin
Lysozyme
Tear Osmolarity
Matrix metalloproteinase-9 (MMP-9)
Cytokines: IL-1β, TNF-α, IL-6
Pathology
- Tear film instability
Meibomian gland dysfunction (MGD)
Increased osmolarity
Decreased tear production
Ocular surface damage
bottom of page